SCF ENCYCLOPEDIA ENTRY
DISSEMINATED INTRAVASCULAR COAGULATION (POSTPARTUM DIC)
SCF-RDOS Registry Code: SCF-RDOS-PPD-HM-007
Disease Type Classification: Hematologic Catastrophic Disorder → Consumptive Coagulopathy Syndrome → Postpartum Disseminated Intravascular Coagulation
Adaptive Module Activation:
- Universal Core Module
- Hematologic Disease Expansion
- Coagulation System Expansion
- Endothelial Dysfunction Expansion
- Immunothrombotic Expansion
- Multiorgan Failure Expansion
- Obstetric Emergency Expansion
⸻
1. SCOPE & POSITIONING
Etiology / Classification
Disseminated Intravascular Coagulation (DIC) is a life-threatening acquired systemic coagulopathy characterized by uncontrolled activation of coagulation pathways, widespread microvascular thrombosis, progressive consumption of clotting factors and platelets, secondary fibrinolysis, and catastrophic hemorrhagic instability.
Postpartum DIC represents one of the most severe maternal emergencies and frequently occurs secondary to major obstetric complications including:
- Massive postpartum hemorrhage
- Placental abruption
- Amniotic fluid embolism
- HELLP syndrome
- Severe preeclampsia
- Acute fatty liver of pregnancy
- Retained products of conception
- Maternal sepsis
- Septic abortion
- Uterine rupture
Within the SCF framework, Postpartum DIC is classified as:
A catastrophic maternal immunothrombohemorrhagic collapse syndrome characterized by uncontrolled coagulation activation, endothelial failure, consumptive depletion of hemostatic reserves, microvascular thrombosis, and progressive multiorgan dysfunction.
⸻
SCF Classification
SCF Disease Category: Catastrophic Hemostatic Collapse Syndrome
SCF Functional Class:
Maternal Immunothrombotic-Coagulation Failure Disorder
SCF Fault Tier Classification
Tier | Classification |
Tier I | Endothelial Activation and Coagulation Triggering |
Tier II | Systemic Thrombin Amplification |
Tier III | Consumptive Coagulopathy |
Tier IV | Hemorrhagic-Thrombotic Instability |
Tier V | Multiorgan Perfusion Failure |
Tier VI | Catastrophic Maternal Collapse Syndrome |
⸻
Clinical Significance
Postpartum DIC is among the most lethal obstetric disorders and frequently serves as the terminal pathway linking obstetric catastrophe to maternal mortality.
Potential complications include:
- Massive hemorrhage
- Hemorrhagic shock
- Acute kidney injury
- Acute liver injury
- Acute respiratory distress syndrome (ARDS)
- Cerebral ischemia
- Myocardial injury
- Pituitary infarction
- Multiorgan failure
- Maternal death
⸻
SCF Domain Alignment
Primary Domains:
- Hematologic
- Coagulation
- Endothelial
- Vascular
Secondary Domains:
- Immune
- Renal
- Hepatic
- Cardiopulmonary
⸻
2. ETIOPATHOGENIC CORE
Primary Cause
Postpartum DIC develops when a massive procoagulant stimulus overwhelms physiologic hemostatic regulation, producing uncontrolled thrombin generation throughout the circulation.
This initiates simultaneous:
- Clot formation
- Platelet consumption
- Coagulation factor depletion
- Fibrinolytic activation
- Endothelial injury
Resulting in concurrent thrombosis and hemorrhage.
⸻
Key Drivers
Driver A — Tissue Factor Storm
Major obstetric triggers release large quantities of:
- Tissue factor
- Placental thromboplastin
- Procoagulant microparticles
Result:
- Explosive thrombin generation
⸻
Driver B — Endothelial Catastrophe
Activated endothelium releases:
- von Willebrand factor
- Proinflammatory cytokines
- Procoagulant mediators
Result:
- Amplification of coagulation
⸻
Driver C — Consumptive Factor Exhaustion
Ongoing clot formation consumes:
- Fibrinogen
- Platelets
- Factor V
- Factor VIII
- Other coagulation proteins
Result:
- Hemostatic failure
⸻
Driver D — Hyperfibrinolytic Activation
Secondary activation of fibrinolysis causes:
- Clot breakdown
- Elevated D-dimer formation
- Further bleeding risk
Result:
- Unstable hemostasis
⸻
Driver E — Microvascular Thrombosis
Diffuse fibrin deposition occurs within:
- Kidneys
- Liver
- Lungs
- Brain
- Placenta (if pregnancy ongoing)
Result:
- Organ ischemia
⸻
3. SCF FAULT ARCHITECTURE
SCF Tier | Fault Node | Consequence |
Tier I | Tissue Factor Activation Node | Coagulation initiation |
Tier I | Endothelial Activation Node | Prothrombotic signaling |
Tier II | Thrombin Amplification Node | Widespread clot formation |
Tier II | Platelet Consumption Node | Progressive thrombocytopenia |
Tier III | Fibrinogen Depletion Node | Clot instability |
Tier III | Consumptive Coagulopathy Node | Hemostatic collapse |
Tier IV | Hyperfibrinolysis Node | Severe bleeding |
Tier IV | Microvascular Thrombosis Node | Tissue ischemia |
Tier V | Organ Perfusion Failure Node | Multiorgan dysfunction |
Tier VI | Catastrophic Collapse Node | Maternal mortality risk |
⸻
4. PATHOGENESIS FLOW (SCF LOGIC)
Obstetric Catastrophic Trigger
↓
Massive Tissue Factor Release
↓
Systemic Coagulation Activation
↓
Thrombin Explosion
↓
Diffuse Fibrin Formation
↓
Microvascular Thrombosis
↓
Platelet Consumption
↓
Coagulation Factor Depletion
↓
Hyperfibrinolysis
↓
Simultaneous
Hemorrhage
Organ Ischemia
↓
Multiorgan Dysfunction
↓
Maternal Collapse
⸻
5. CLINICAL SPECTRUM
Stage | Clinical State | Characteristics |
Stage 0 | Procoagulant Activation State | Laboratory changes only |
Stage I | Early DIC | Mild thrombocytopenia |
Stage II | Progressive Consumptive Coagulopathy | Factor depletion |
Stage III | Established DIC | Clinical bleeding |
Stage IV | Severe Hemorrhagic-Thrombotic Disease | Organ injury begins |
Stage V | Multiorgan DIC Syndrome | Major organ dysfunction |
Stage VI | Catastrophic Maternal Collapse | Critical illness |
⸻
6. SCF TRINITY FRAMEWORK MAPPING
Trinity Axis I — Structural Integrity
Affected Systems:
- Endothelium
- Platelets
- Fibrin matrix
- Microvasculature
Primary Failure:
- Hemostatic structural collapse
⸻
Trinity Axis II — Energetic Integrity
Affected Systems:
- Cellular oxygen delivery
- Organ perfusion
- Mitochondrial bioenergetics
Primary Failure:
- Ischemic energy deprivation
⸻
Trinity Axis III — Informational Integrity
Affected Systems:
- Coagulation signaling
- Endothelial communication
- Immune-hemostatic regulation
Primary Failure:
- Immunothrombotic signaling runaway activation
⸻
7. DIC EXPANSION MODULE
Clinical Subtype Registry
Type A
Hemorrhage-Induced Postpartum DIC
Characteristics:
- Massive postpartum hemorrhage trigger
- Fibrinogen depletion dominant
⸻
Type B
Placental Catastrophe DIC
Characteristics:
- Placental abruption
- Tissue factor release dominant
⸻
Type C
HELLP-Associated DIC
Characteristics:
- Endothelial injury
- Microangiopathic pathology
⸻
Type D
Septic DIC
Characteristics:
- Infection-driven coagulation activation
- Cytokine storm involvement
⸻
Type E
Amniotic Fluid Embolism DIC
Characteristics:
- Fulminant onset
- Catastrophic coagulopathy
⸻
8. MULTI-OMICS PATHOGENESIS MAP
Omics Layer | SCF Interpretation |
Genomics | Variants affecting coagulation factors, fibrinolysis, platelet regulation, complement activity, and endothelial resilience |
Transcriptomics | Massive activation of tissue factor, cytokine, thrombin, and endothelial activation pathways |
Proteomics | Fibrinogen depletion, coagulation factor consumption, platelet activation proteins, endothelial injury mediators |
Metabolomics | Severe hypoxia signatures, lactate accumulation, oxidative stress metabolites |
Epigenomics | Acute inflammatory-hemostatic reprogramming |
Interactomics | Tissue factor-thrombin-fibrin, complement-coagulation, platelet-endothelial network dysregulation |
Connectomics | Hemostatic-endothelial-organ perfusion communication collapse |
Biomechanicalomics | Failure of fibrin architecture and microvascular flow dynamics |
⸻
9. SCF PCR THERAPEUTIC STRATEGY
PREVENTATIVE
Objectives
Prevent transition from obstetric trigger to systemic DIC.
Targets:
- Early trigger recognition
- Fibrinogen preservation
- Hemostatic monitoring
- Rapid obstetric intervention
⸻
CURATIVE
Objectives
Stop ongoing coagulation consumption and restore hemostatic competence.
Targets:
- Underlying trigger
- Factor depletion
- Platelet loss
- Hyperfibrinolysis
- Organ hypoperfusion
Interventions:
- Immediate treatment of precipitating cause
- Massive transfusion protocols
- Fibrinogen replacement
- Platelet replacement
- Critical care stabilization
⸻
RESTORATIVE
Objectives
Re-establish endothelial, coagulation, and organ-system resilience.
Targets:
- Endothelial repair
- Organ recovery
- Mitochondrial restoration
- Hematologic normalization
Potential strategies:
- Precision endothelial stabilization platforms
- SCF-derived immunothrombotic regulators
- Organ recovery therapeutics
- Perfusion preservation systems
⸻
10. CURRENT STANDARD OF CARE
Diagnostic Evaluation
Clinical Assessment
- Active bleeding
- Hemodynamic instability
- Organ dysfunction
- Shock evaluation
⸻
Laboratory Evaluation
Core Tests:
- Platelet count
- Fibrinogen
- PT/INR
- aPTT
- D-dimer
- FDPs
Advanced Testing:
- TEG
- ROTEM
- Factor assays
⸻
Organ Monitoring
- Renal function
- Liver function
- Lactate
- Cardiac biomarkers
- Respiratory assessment
⸻
Treatment
Immediate Management
- Treat underlying obstetric trigger
- Hemodynamic stabilization
- Critical care support
⸻
Hemostatic Resuscitation
May include:
- Cryoprecipitate
- Fibrinogen concentrate
- Fresh frozen plasma
- Platelet transfusion
- Packed red blood cells
⸻
Advanced Care
- Massive transfusion protocol
- Mechanical organ support
- Intensive care management
⸻
11. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES
SCF Target Cluster A
Precision Hemostasis Platform
Targets:
- Thrombin regulation
- Fibrin stabilization
- Platelet preservation
⸻
SCF Target Cluster B
Endothelial Protection Platform
Targets:
- Glycocalyx preservation
- Endothelial barrier integrity
- Microvascular stabilization
⸻
SCF Target Cluster C
Immunothrombotic Modulation Platform
Targets:
- Complement activation
- Cytokine amplification
- Tissue factor signaling
⸻
SCF Target Cluster D
Organ Perfusion Preservation Platform
Targets:
- Microvascular flow
- Ischemia prevention
- Mitochondrial protection
⸻
12. TRANSLATIONAL BLUEPRINT
Diagnostic Biomarkers
Hemostatic
- Fibrinogen
- D-dimer
- PT/INR
- aPTT
- FDPs
Platelet
- Platelet count
- Platelet activation markers
Endothelial
- von Willebrand factor
- Soluble thrombomodulin
- Syndecan-1
Organ Injury
- Creatinine
- ALT/AST
- Lactate
- Troponin
⸻
Clinical Endpoints
Primary:
- Resolution of DIC
Secondary:
- Restoration of fibrinogen levels
- Hemorrhage control
- Organ preservation
- Maternal survival
⸻
FDA Translational Pathway
Preclinical
↓
IND
↓
Phase I Safety
↓
Phase II Hemostatic Efficacy
↓
Phase III Maternal Outcomes
↓
NDA/BLA Submission
⸻
13. SCF DBI INTERPRETATION
Decentralized Biological Intelligence Failure
Cellular Layer
Endothelial cells, platelets, and coagulation proteins enter uncontrolled activation-consumption cycles.
⸻
Tissue Layer
Microvascular networks become simultaneously obstructed by fibrin and incapable of maintaining hemostasis.
⸻
Organ Layer
Critical organs experience concurrent ischemia and hemorrhagic instability.
⸻
System Layer
Coagulation, immune, endothelial, and perfusion systems become locked in a self-amplifying pathological loop.
⸻
Whole-Organism Layer
Maternal physiology transitions from adaptive hemostasis to catastrophic systemic collapse due to runaway immunothrombotic activation.
⸻
14. SCF LAYMAN’S SUMMARY
Disseminated Intravascular Coagulation (DIC) is one of the most dangerous complications that can occur after childbirth. In DIC, the body’s clotting system becomes overactivated, forming tiny clots throughout the bloodstream while simultaneously using up the clotting factors needed to stop bleeding.
According to the SCF model, a major obstetric event such as severe hemorrhage, placental abruption, amniotic fluid embolism, sepsis, or HELLP syndrome triggers an uncontrolled coagulation response. As clotting factors and platelets are consumed, the body loses the ability to stop bleeding while organs become damaged from blocked blood flow.
Common findings include:
- Severe bleeding
- Low platelet counts
- Abnormal clotting tests
- Shock
- Kidney injury
- Liver injury
- Respiratory failure
- Multiorgan dysfunction
Postpartum DIC is a true medical emergency requiring immediate intensive care treatment to prevent maternal death.
⸻
SCF-RDOS INDICATION SUMMARY
Parameter | Classification |
Disease | Disseminated Intravascular Coagulation (Postpartum DIC) |
Registry Code | SCF-RDOS-PPD-HM-007 |
Disease Type | Catastrophic Hemostatic Collapse Syndrome |
Adaptive Modules Activated | Hematologic + Coagulation + Endothelial + Immunothrombotic + Obstetric Emergency |
SCF Fault Tier | I–VI |
Primary Systems | Hematologic, Coagulation, Endothelial, Vascular |
Principal Fault Nodes | Thrombin Amplification, Consumptive Coagulopathy, Microvascular Thrombosis |
Mortality Risk | Extremely High Without Immediate Treatment |
Morbidity Risk | Extremely High |
Chronicity Risk | Low (Acute Catastrophic Event) |
SCF-PCR Applicability | Preventative, Curative, Restorative |